Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) EBIT (2017 - 2025)

Historic EBIT for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $46.1 million.

  • Inspire Medical Systems' EBIT rose 4462.11% to $46.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $51.0 million, marking a year-over-year increase of 4121.33%. This contributed to the annual value of $51.0 million for FY2025, which is 4121.33% up from last year.
  • Per Inspire Medical Systems' latest filing, its EBIT stood at $46.1 million for Q4 2025, which was up 4462.11% from $9.6 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year EBIT high stood at $46.1 million for Q4 2025, and its period low was -$19.5 million during Q1 2023.
  • In the last 5 years, Inspire Medical Systems' EBIT had a median value of -$6.6 million in 2021 and averaged -$2.0 million.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 287522.39% in 2023, then plummeted by 16503.24% in 2025.
  • Inspire Medical Systems' EBIT (Quarter) stood at -$1.8 million in 2021, then skyrocketed by 81.6% to -$335000.0 in 2022, then soared by 2875.22% to $9.3 million in 2023, then skyrocketed by 242.95% to $31.9 million in 2024, then surged by 44.62% to $46.1 million in 2025.
  • Its last three reported values are $46.1 million in Q4 2025, $9.6 million for Q3 2025, and -$3.3 million during Q2 2025.